{"altmetric_id":2303086,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["220847274636880"],"posts_count":1},"total":{"posts_count":4},"twitter":{"unique_users_count":3,"unique_users":["therapeuticsh","cmtherapeutic","medicineh"],"posts_count":3}},"selected_quotes":["New article: Pazopanib as First-Line Treatment for Advanced RCC #LibertasAcademica #cancer #therapeutics"],"citation":{"altmetric_jid":"4f6fa67a3cf058f61000977f","authors":["Edward Rampersaud","Taylor Lu"],"doi":"10.4137\/cmt.s9280","first_seen_on":"2014-04-24T22:04:45+00:00","issns":["1179-559X"],"journal":"Clinical Medicine Insights: Therapeutics","last_mentioned_on":1398279025,"links":["http:\/\/www.la-press.com\/pazopanibthe-latest-first-line-standard-of-care-targeted-kinase-inhibi-article-a4169","http:\/\/www.la-press.com\/pazopanibthe-latest-first-line-standard-of-care-targeted-kinase-inhibi-article-a4169?source=rss","http:\/\/www.la-press.com\/article.php?article_id=4169"],"pubdate":"2014-04-01T00:00:00+00:00","startpage":"25","title":"Pazopanib&mdash;the Latest First-Line Standard of Care Targeted Kinase Inhibitor for the Treatment of Advanced Renal Cell Carcinoma","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/pazopanibampmdashthe-latest-firstline-standard-care-targeted-kinase-inhibitor-treatment-advanced-ren"},"altmetric_score":{"score":2.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.75},"context_for_score":{"all":{"total_number_of_other_articles":7306409,"mean":6.3705710494094,"rank":2741569,"this_scored_higher_than_pct":62,"this_scored_higher_than":4541839,"rank_type":"exact","sample_size":7306409,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":172983,"mean":7.1359751072368,"rank":49637,"this_scored_higher_than_pct":70,"this_scored_higher_than":122608,"rank_type":"exact","sample_size":172983,"percentile":70},"this_journal":{"total_number_of_other_articles":50,"mean":1.8214285714286,"rank":11,"this_scored_higher_than_pct":76,"this_scored_higher_than":38,"rank_type":"exact","sample_size":50,"percentile":76},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":[],"by_discipline":[]}}},"posts":{"facebook":[{"title":"Pazopanib\u2014the Latest First-Line Standard of Care Targeted Kinase Inh","url":"https:\/\/www.facebook.com\/220847274636880\/posts\/648151058573164","license":"public","citation_ids":[2303086],"posted_on":"2014-04-23T18:50:25+00:00","summary":"New article in Clinical Medicine Insights: Therapeutics: Pazopanib as First-Line Treatment for Advanced RCC.","author":{"name":"Libertas Academica","url":"https:\/\/www.facebook.com\/220847274636880","facebook_wall_name":"Libertas Academica","image":"https:\/\/graph.facebook.com\/220847274636880\/picture","id_on_source":"220847274636880"}}],"twitter":[{"url":"http:\/\/twitter.com\/therapeuticsh\/status\/458751280144330752","license":"datasift","citation_ids":[2303086],"posted_on":"2014-04-22T23:36:43+00:00","author":{"name":"Drugs Therapeutics","url":"http:\/\/www.la-press.com\/home-drugs-therapeutics","image":"http:\/\/pbs.twimg.com\/profile_images\/350532586\/177449_logo_final_graphiconly_normal.JPG","description":"See all open access articles published in drugs and therapeutics by Libertas Academica","id_on_source":"therapeuticsh","tweeter_id":"63339500","followers":29},"tweet_id":"458751280144330752"},{"url":"http:\/\/twitter.com\/cmtherapeutic\/status\/458754420759478272","license":"datasift","citation_ids":[2303086],"posted_on":"2014-04-22T23:49:11+00:00","author":{"name":"CM Therapeutics","url":"http:\/\/www.la-press.com\/clinical-medicine-therapeutics-journal-j133","image":"https:\/\/pbs.twimg.com\/profile_images\/180208899\/177449_logo_final_graphiconly_normal.JPG","description":"Clinical Medicine: Therapeutics: an open access journal by Libertas Academica","id_on_source":"cmtherapeutic","tweeter_id":"34824618","geo":{"lt":null,"ln":null},"followers":23},"tweet_id":"458754420759478272"},{"url":"http:\/\/twitter.com\/medicineh\/status\/458763747985592320","license":"datasift","citation_ids":[2303086],"posted_on":"2014-04-23T00:26:15+00:00","author":{"name":"Medicine","url":"http:\/\/www.la-press.com\/home-medicine","image":"http:\/\/pbs.twimg.com\/profile_images\/350545441\/177449_logo_final_graphiconly_normal.JPG","description":"See all open access articles published in medicine by Libertas Academica","id_on_source":"medicineh","tweeter_id":"63341817","followers":40},"tweet_id":"458763747985592320"}]}}